Cardinal Health

500 articles with Cardinal Health

• Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance

  2/2/2023

  Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2023 revenues of $51.5 billion, an increase of 13% from the second quarter of fiscal year 2022.

• Cardinal Health Teams Up with Palantir to Deliver a Clinically Integrated Supply Chain Solution

  1/26/2023

  Cardinal Health announced that it has entered into a strategic collaboration with Palantir Technologies Inc., a leading builder of operating systems for the modern enterprise, to design a solution that will give health systems and hospitals dynamic purchase decision insights in order to quickly improve their bottom line.

• Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2023 on February 2

  1/3/2023

  Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2, prior to the opening of trading on the New York Stock Exchange.

• Cardinal Health Names Aaron Alt Chief Financial Officer

  12/19/2022

  Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company's new chief financial officer (CFO).

• Cardinal Health Reports First Quarter Fiscal 2023 Results

  11/4/2022

  Cardinal Health reported first quarter fiscal year 2023 revenues of $49.6 billion, an increase of 13% from the first quarter of last year.

• New Cardinal Health research highlights rheumatologists' increasing confidence in biosimilars

  10/19/2022

  Cardinal Health released its third edition of Rheumatology Insights, a research report based on surveys with more than 100 rheumatologists nationwide that focuses on key trends impacting one of the fastest-growing areas of specialty medicine.

• Cardinal Health to Announce First-Quarter Results for Fiscal Year 2023 on November 4

  9/27/2022

  Cardinal Health plans to release first-quarter financial results for its fiscal year 2023 on November 4, prior to the opening of trading on the New York Stock Exchange.

• Cardinal Health Announces Pharmaceutical Segment Organizational Changes

  9/8/2022

  Cardinal Health announced Debbie Weitzman, current President of Pharmaceutical Distribution, will become CEO of the Company's Pharmaceutical Segment.

• Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022

  8/11/2022

  Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022.

• Cardinal Health Announces Leadership Changes

  8/11/2022

  Cardinal Health announced that its Board of Directors has elected Jason Hollar as the company's next Chief Executive Officer, effective September 1, 2022.

• Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2022 on August 11

  7/7/2022

  Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2022 on August 11, prior to the opening of trading on the New York Stock Exchange.

• Cardinal Health Oncology Insights: Oncologists Report High Levels of Burnout Symptoms, Increased Stress

  6/3/2022

  Nearly 90% of oncologists said they experience emotional exhaustion at work, and more than two-thirds said they experience additional symptoms of burnout, such as cynicism, detachment and feeling unaccomplished or ineffective, according to new research released from Cardinal Health Specialty Solutions in the eleventh edition of Oncology Insights, a biannual research-based report series analyzing the views of oncologists nationwide.

• Cardinal Health Raises Quarterly Dividend - May 10, 2022

  5/10/2022

  Cardinal Health announced that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus.

• Cardinal Health Reports Third Quarter Fiscal 2022 Results

  5/5/2022

  Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2022 revenues of $44.8 billion, an increase of 14% from the third quarter of last year.

• Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2022 on May 5

  4/1/2022

  Cardinal Health plans to release third-quarter financial results for its fiscal year 2022 on May 5 prior to the opening of trading on the New York Stock Exchange.

• 

  Teva, Allergan Reach Opioid Settlement Agreement with Rhode Island

  3/22/2022

  Teva Pharmaceuticals and AbbVie will pay the state of Rhode Island a combined $28.5 million to settle opioid-related claims against the companies. 

• New Cardinal Health surgical drape helps reduce surgical site contamination risk

  3/17/2022

  Cardinal Health launched the first surgical incise drape using industry-leading antiseptic Chlorhexidine Gluconate.

• Cardinal Health Board of Directors Approves Quarterly Dividend - Feb 08, 2022

  2/8/2022

  Cardinal Health announced that its Board of Directors approved a quarterly dividend of $0.4908 per share.

• Cardinal Health Reports Second Quarter Fiscal 2022 Results

  2/3/2022

  Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year.

• Cardinal Health Provides Medical Segment Fiscal Year 2022 Financial Update

  1/10/2022

  Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment.